Status:
COMPLETED
Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin
Lead Sponsor:
Sanwa Kagaku Kenkyusho Co., Ltd.
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20-74 years
Phase:
PHASE3
Brief Summary
In this study, the effect of miglitol on daily plasma glucose will be evaluated in type 2 diabetic patients treated with insulin.
Eligibility Criteria
Inclusion
- type2 diabetes
- postprandial plasma glucose levels ≧180mg/dl
Exclusion
- type1 diabetes
- AST(GOT) or ALT(GPT) ≧100IU/l
- creatinine ≧2.0mg/dl
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00213122
Last Update
September 28 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ibaraki, Japan